38 related articles for article (PubMed ID: 37060737)
1. Impact of the COVID-19 pandemic on cancer death locations in Japan: an analysis up to February 2023 on excess mortality.
Nomura S; Nishio M; Abe SK; Eguchi A; Inoue M; Suzuki M; Hashizume M
J Epidemiol; 2023 Oct; ():. PubMed ID: 37866926
[TBL] [Abstract][Full Text] [Related]
2. Changes in the place of death before and during the COVID-19 pandemic in Japan.
Shibata M; Otsuka Y; Hagiya H; Koyama T; Kashiwagi H; Otsuka F
PLoS One; 2024; 19(2):e0299700. PubMed ID: 38416759
[TBL] [Abstract][Full Text] [Related]
3. Excess mortality during the Coronavirus disease pandemic in Korea.
Han C; Jang H; Oh J
BMC Public Health; 2023 Sep; 23(1):1698. PubMed ID: 37660007
[TBL] [Abstract][Full Text] [Related]
4. A population-based study of the trend in SARS-CoV-2 diagnostic modalities from the beginning of the pandemic to the Omicron surge in Kyoto City, Kyoto, Japan.
Kyo H; Patel SA; Yamamoto M; Matsumura Y; Ikeda T; Nagao M
BMC Public Health; 2023 Dec; 23(1):2551. PubMed ID: 38129830
[TBL] [Abstract][Full Text] [Related]
5. Excess Mortality at Veterans Health Administration Facilities During the COVID-19 Pandemic.
Tenso K; Strombotne KL; Feyman Y; Auty SG; Legler A; Griffith KN
Med Care; 2023 Jul; 61(7):456-461. PubMed ID: 37219062
[TBL] [Abstract][Full Text] [Related]
6. Direct and indirect mortality impacts of the COVID-19 pandemic in the US, March 2020-April 2021.
Lee WE; Park SW; Weinberger DM; Olson D; Simonsen L; Grenfell BT; Viboud C
medRxiv; 2022 Feb; ():. PubMed ID: 35194617
[TBL] [Abstract][Full Text] [Related]
7. Decomposing mechanisms of COVID-19 mortality in empirical datasets: A modeling study.
Zhang T; Qiao J; Hayashi K; Nishiura H
J Theor Biol; 2024 May; 584():111771. PubMed ID: 38452809
[TBL] [Abstract][Full Text] [Related]
8. Changes in cardiovascular mortality in Chile during the COVID-19 pandemic.
Chang SW; Zitko P; Passi-Solar Á; Danaei G; Margozzini P
Heart; 2022 Oct; 108(21):1716-1721. PubMed ID: 35105666
[TBL] [Abstract][Full Text] [Related]
9. Maintaining health-system functionality in response to the surge of COVID-19 cases due to the Omicron variant, Japan.
Moriyama Y; Takaya S; Nishijima T; Sobel HL; Ohmagari N
Western Pac Surveill Response J; 2023; 14(5 Spec edition):1-6. PubMed ID: 38450059
[TBL] [Abstract][Full Text] [Related]
10. Excess mortality among kidney transplant recipients: Impact of COVID-19-related deaths during the pandemic.
Cristelli MP; Fortaleza CMCB; Pereira JFCA; Taddeo JB; Viana LA; Requião-Moura LR; Chow CYZ; Nakamura MR; Tedesco-Silva H; Medina-Pestana J
Transpl Infect Dis; 2024 Feb; 26(1):e14204. PubMed ID: 38010722
[TBL] [Abstract][Full Text] [Related]
11. Assessing Excess Mortality of Baby Boomers from the COVID-19 Pandemic: Taiwan Omicron-naïve Cohort.
Lin TY; Hsu CY; Yen AM; Chen SL; Chen TH
J Epidemiol Glob Health; 2024 Jun; ():. PubMed ID: 38902563
[TBL] [Abstract][Full Text] [Related]
12. Have increased deaths at home during the pandemic returned to pre-pandemic levels? An analysis of publicly available Scottish death registrations.
Savinc J; Atherton IM
J Public Health (Oxf); 2023 Nov; 45(4):e664-e667. PubMed ID: 37596241
[TBL] [Abstract][Full Text] [Related]
13. Change in the Proportion of Death at Home during the COVID-19 Pandemic and Its Associated Factors in the Municipality Level: A Nationwide Study in Japan.
Sun Y; Iwagami M; Inokuchi R; Sakata N; Ito T; Taniguchi Y; Yoshie S; Tamiya N
JMA J; 2024 Apr; 7(2):213-221. PubMed ID: 38721095
[TBL] [Abstract][Full Text] [Related]
14. Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan.
Gibo M; Kojima S; Fujisawa A; Kikuchi T; Fukushima M
Cureus; 2024 Apr; 16(4):e57860. PubMed ID: 38721172
[TBL] [Abstract][Full Text] [Related]
15. The mRNA Vaccination Rate Is Negatively and the Proportion of Elderly Individuals Is Positively Associated With the Excess Mortality Rate After 2020 in Japan.
Ato D
Cureus; 2024 Jan; 16(1):e52490. PubMed ID: 38371060
[TBL] [Abstract][Full Text] [Related]
16. Changes in cerebrovascular disease-related deaths and their location during the COVID-19 pandemic in Japan.
Nomura S; Eguchi A; Ghaznavi C; Yamasaki L; Rauniyar SK; Tanoue Y; Kawashima T; Yoneoka D; Kohsaka S; Suzuki M; Hashizume M
Public Health; 2023 May; 218():176-179. PubMed ID: 37060737
[TBL] [Abstract][Full Text] [Related]
17. Excess deaths from COVID-19 in Japan and 47 prefectures from January through June 2021.
Nomura S; Eguchi A; Tanoue Y; Yoneoka D; Kawashima T; Suzuki M; Hashizume M
Public Health; 2022 Feb; 203():15-18. PubMed ID: 35016070
[TBL] [Abstract][Full Text] [Related]
18. Excess deaths from non-COVID-19-related causes in Japan and 47 prefectures from January 2020 through May 2021 by place of death.
Nomura S; Eguchi A; Ghaznavi C; Tanoue Y; Kawashima T; Yoneoka D; Yamasaki L; Suzuki M; Hashizume M
SSM Popul Health; 2022 Sep; 19():101196. PubMed ID: 35958225
[TBL] [Abstract][Full Text] [Related]
19. Excess All-Cause Deaths during Coronavirus Disease Pandemic, Japan, January-May 2020
Kawashima T; Nomura S; Tanoue Y; Yoneoka D; Eguchi A; Ng CFS; Matsuura K; Shi S; Makiyama K; Uryu S; Kawamura Y; Takayanagi S; Gilmour S; Miyata H; Sunagawa T; Takahashi T; Tsuchihashi Y; Kobayashi Y; Arima Y; Kanou K; Suzuki M; Hashizume M
Emerg Infect Dis; 2021 Mar; 27(3):789-795. PubMed ID: 33622468
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
